Trial Details
COMPLETEDBasic Information
| Clinical ID | c1386 |
|---|---|
| Identifier | NCT05118919 |
| Trial Title | A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: BGP-014|BIOLOGICAL: Placebo |
Participant Information
| Sponsor | BioGaia Pharma AB |
|---|---|
| City | Linköping |
| Country/Region | Sweden |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2022-02-09 |
|---|---|
| Primary Completion Date | 2024-12-31 |
| Completion Date | 2024-12-31 |